Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Not yet recruiting 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Dermatologic 1Breast 1

Conditions

Meningeal Neoplasms 1Melanoma 1Lung Neoplasms 1Breast Neoplasms 1

Interventions

Specimen Handling 625pembrolizumab 606Magnetic Resonance Spectroscopy 550Carboplatin 448Cisplatin 396Cyclophosphamide 394Biopsy 371Paclitaxel 323Nivolumab 322Gemcitabine 317Radiotherapy 283Bevacizumab 242Dexamethasone 222fludarabine 213Docetaxel 198durvalumab 194Oxaliplatin 187venetoclax 186atezolizumab 179Fluorouracil 176Rituximab 175Pemetrexed 172Capecitabine 167Radiation 164Doxorubicin 164Radiosurgery 159Ipilimumab 145Etoposide 142Leucovorin 140Lenalidomide 138

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × gadopiclenol × 90 days × Clear all
NCT06086704 2026-05-18

Study of 18F-FFNP Breast PET/MRI

University of Wisconsin, Madison

Phase 2 Recruiting
53 enrolled
Breast

Breast Neoplasms

NCT07415018 2026-04-14

Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease

M.D. Anderson Cancer Center

Phase NA Not yet recruiting
40 enrolled

Meningeal Neoplasms

NCT07492121 2026-03-25

GAPIMET

University of Zurich

Phase 2 Not yet recruiting
180 enrolled
DermatologicThoracic

Lung Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡